poisar

Stock

NovaBridge Biosciences NBP

$1.90+1.60%

Overview

NBP market data

Price History

NBP price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.21
Diluted earnings per share over the trailing twelve months.
Beta
1.57
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-439.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.46 – $6.79
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $215.8M · P/B 1.98 · P/S 4.56.

Company News

3 captured
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026Globenewswire Inc · Jul 24, 2026, 9:15 PM
NovaBridge Names Srishti Gupta CEO As Sean Fu Steps DownBenzinga · Jun 29, 2026, 11:15 AM
NovaBridge Biosciences Says FDA Grants Fast Track Designation To Givastomig In First-Line HER2-Negative Metastatic Gastric CancerBenzinga · Jun 16, 2026, 11:25 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock